EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

Derya TilkiRoderick C N van den BerghErik BriersThomas Van den BroeckOliver BrunckhorstJulie DarraughDaniel EberliGert De MeerleerMaria De SantisAndrea FarolfiGiorgio GandagliaSilke GillessenNikolaos GrivasAnn M HenryMichael LardasGeert J L H van LeendersMatthew LiewEstefania Linares EspinosJan OldenburgInge M van OortDaniela E Oprea-LagerGuillaume PloussardMatthew J RobertsOlivier RouvièreIvo G SchootsNatasha SchoutenEmma J SmithJohan StranneThomas WiegelPeter-Paul M WillemsePhilip Cornford

Published in: European urology (2024)

This article summarises the 2024 guidelines for the treatment of relapsing, metastatic, and castration-resistant prostate cancer. These guidelines are based on evidence and guide doctors in discussing treatment decisions with their patients. The guidelines are updated every year.

Keyphrases

prostate cancer
multiple sclerosis
squamous cell carcinoma
radical prostatectomy
end stage renal disease
rheumatoid arthritis
ejection fraction
systemic lupus erythematosus
disease activity
combination therapy
replacement therapy